EUVIMEDEUVIMED entdecken
Crossref

Zilebesiran – nový princíp a nová nádej v liečbe hypertenzie / Zilebesiran – a new principle and new hope in the treatment of hypertension

Juraj Dúbrava

Cardiology Letters · 02.11.2024 · 33 (5) · 338-343

DOI: 10.4149/cardiol_2024_5_6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology Letters, online erschienen am 02.11.2024. Verfasst von Juraj Dúbrava.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Dúbrava, J. (2024). Zilebesiran – nový princíp a nová nádej v liečbe hypertenzie / Zilebesiran – a new principle and new hope in the treatment of hypertension. Cardiology Letters, 33(5), 338-343. https://doi.org/10.4149/cardiol_2024_5_6

Vancouver

Dúbrava J. Zilebesiran – nový princíp a nová nádej v liečbe hypertenzie / Zilebesiran – a new principle and new hope in the treatment of hypertension. Cardiology Letters. 2024;33(5):338-343. doi:10.4149/cardiol_2024_5_6

BibTeX
@article{Dbrava2024,
  author = {Dúbrava, Juraj},
  title = {Zilebesiran – nový princíp a nová nádej v liečbe hypertenzie / Zilebesiran – a new principle and new hope in the treatment of hypertension},
  journal = {Cardiology Letters},
  year = {2024},
  volume = {33},
  number = {5},
  pages = {338--343},
  doi = {10.4149/cardiol_2024_5_6}
}
Kostenlos starten →